Brexpiprazole: A new option in treating agitation in Alzheimer's dementia—Insights from transgenic mouse models

MLA

Naoki Amada, et al. “Brexpiprazole: A New Option in Treating Agitation in Alzheimer’s Dementia—Insights from Transgenic Mouse Models.” Neuropsychopharmacology Reports, vol. 44, no. 3, Sept. 2024, pp. 557–68. EBSCOhost, https://doi.org/10.1002/npr2.12461.

APA

Naoki Amada, Shinji Sato, Dai Ishikawa, Mai Nakamura, Mikio Suzuki, Takashi Futamura, & Kenji Maeda. (2024). Brexpiprazole: A new option in treating agitation in Alzheimer’s dementia—Insights from transgenic mouse models. Neuropsychopharmacology Reports, 44(3), 557–568. https://doi.org/10.1002/npr2.12461

Chicago

Naoki Amada, Shinji Sato, Dai Ishikawa, Mai Nakamura, Mikio Suzuki, Takashi Futamura, and Kenji Maeda. 2024. “Brexpiprazole: A New Option in Treating Agitation in Alzheimer’s Dementia—Insights from Transgenic Mouse Models.” Neuropsychopharmacology Reports 44 (3): 557–68. doi:10.1002/npr2.12461.